<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03473158</url>
  </required_header>
  <id_info>
    <org_study_id>IVF-001-2018</org_study_id>
    <nct_id>NCT03473158</nct_id>
  </id_info>
  <brief_title>Fetal Reduction: Mechanical vs Chemical</brief_title>
  <official_title>Early Fetal Reduction Through a Transvaginal Ultrasound Guided Approach in Multifetal Pregnancies: Mechanical Disruption Against Potassium Chloride Injection. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Riyadh Fertility and Reproductive Health center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study multifetal pregnancy reduction (to twins) will be carried out through a&#xD;
      transvaginal route, at an early gestational age (6 weeks - 9weeks + 6days) using 2 methods:&#xD;
      mere mechanical disruption against potassium chloride injection. The 2 methods will be&#xD;
      compared regarding the efficacy, complications and pregnancy outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of multifetal gestations has increased dramatically over the past several&#xD;
      decades. Multiple pregnancies are frequently complicated by maternal and fetal morbidities&#xD;
      and mortalities. Data show that the incidence of morbidity and mortality correlate with fetal&#xD;
      number. In the United Kingdom, the single embryo transfer policy has reduced the incidence of&#xD;
      multifetal gestation. Also, in the United States the ASRM (American society of reproductive&#xD;
      medicine) has revised the guidelines to optimize the number of transferred embryos during&#xD;
      IVF. However in Egypt, transfer of 3 to 4 embryos is still practiced. The procedure of fetal&#xD;
      reduction aims to decrease the occurrence of maternal and perinatal morbidities related to&#xD;
      multifetal gestations. It can be carried out transvaginally or transabdominally under&#xD;
      ultrasound guidance. It may be done by potassium chloride injection through needle injection,&#xD;
      mere mechanical disruption by a needle, or by radiofrequency ablation. In this study&#xD;
      multifetal pregnancy reduction will be carried out through transvaginal route, at an early&#xD;
      gestational age (6 weeks - 9weeks + 6days), and compare the efficacy, complications and&#xD;
      pregnancy outcome using mere mechanical disruption against potassium chloride injection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success of the procedure</measure>
    <time_frame>5 minutes after the end of fetal reduction</time_frame>
    <description>Number of gestational sacs in which fetal heart activity will stop</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of the fetal reduction procedure</measure>
    <time_frame>5 minutes after the end of the procedure when cessation of fetal heart is confirmed</time_frame>
    <description>Duration in minutes needed for each fetus to be reduced (from time of introduction of embryo reduction needle into the gestational sac till fetal heart activity stops)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative vaginal spotting or bleeding</measure>
    <time_frame>within the first week of the procedure i.e. from the end of the procedure till 7 days after the procedure</time_frame>
    <description>Number of participants who will develop vaginal spotting or bleeding related to the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational age at birth</measure>
    <time_frame>On the same day of delivery</time_frame>
    <description>age of pregnancy in weeks and days at time of delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal birth weight</measure>
    <time_frame>On the same day of delivery</time_frame>
    <description>fetal weight in grams at time of delivery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Multiple Pregnancy</condition>
  <arm_group>
    <arm_group_label>Mechanical</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fetal reduction will be achieved by mechanical disruption of the fetal heart till asystole is achieved, and may be aided by partial or total suction of the fetus, using suction device attached to the embryo reduction needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chemical</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fetal reduction will be achieved by injecting 0.5 mL of potassium chloride (Potassium Chloride速 15% , EIPICO, Egypt) into the cardiac region through the embryo reduction needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transvaginal ultrasound</intervention_name>
    <description>using the 6.5mHz intra-cavitary probe (65EC10EA) of ultrasound machine DP-50 (Shenzhen Mindray Bio-Medical Electronics Co., Ltd., P.R.China) to determine the number, site, size and cardiac activity of the fetuses, and monitor the fetal reduction procedure</description>
    <arm_group_label>Chemical</arm_group_label>
    <arm_group_label>Mechanical</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mechanical fetal reduction</intervention_name>
    <description>under transvaginal ultrasound guidance, fetal reduction will be achieved by mechanical disruption of the fetal heart till asystole is achieved, and may be aided by partial or total suction of the fetus, using suction device attached to the embryo reduction needle (Cook速 Ireland Ltd., Limerick, Ireland)</description>
    <arm_group_label>Mechanical</arm_group_label>
    <other_name>Mechanical disruption</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chemical fetal reduction</intervention_name>
    <description>under transvaginal ultrasound guidance, fetal reduction will be achieved by injecting 0.5 mL of potassium chloride (Potassium Chloride速 15% , EIPICO, Egypt) into the cardiac region through the embryo reduction needle (Cook速 Ireland Ltd., Limerick, Ireland)</description>
    <arm_group_label>Chemical</arm_group_label>
    <other_name>Potassium Chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women with multifetal pregnancy (3 fetuses or more)&#xD;
&#xD;
          -  Pregnant women from 6 weeks to 9 weeks + 6 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women with singleton or twin pregnancy&#xD;
&#xD;
          -  Pregnant women before 6 weeks (higher incidence of spontaneous vanishing twin)&#xD;
&#xD;
          -  Pregnant women after 9 weeks + 6 days (the technique is difficult to apply)&#xD;
&#xD;
          -  Pelvic or genital infection&#xD;
&#xD;
          -  Hemorrhagic blood disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan Omar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>March 9, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2018</study_first_posted>
  <last_update_submitted>October 25, 2020</last_update_submitted>
  <last_update_submitted_qc>October 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed AA Wali, MD</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>fetal reduction</keyword>
  <keyword>embryo reduction</keyword>
  <keyword>feticide</keyword>
  <keyword>potassium chloride</keyword>
  <keyword>multiple pregnancy</keyword>
  <keyword>multifetal pregnancy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

